Detalles de la búsqueda
1.
Trial of Sodium Phenylbutyrate-Taurursodiol for Amyotrophic Lateral Sclerosis.
N Engl J Med
; 383(10): 919-930, 2020 09 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32877582
2.
Why a clinical trial is as good as its outcome measure: A framework for the selection and use of cognitive outcome measures for clinical trials of Alzheimer's disease.
Alzheimers Dement
; 19(2): 708-720, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36086926
3.
Memantine ER Maintains Patient Response in Moderate to Severe Alzheimer's Disease: Post Hoc Analyses From a Randomized, Controlled, Clinical Trial of Patients Treated With Cholinesterase Inhibitors.
Alzheimer Dis Assoc Disord
; 32(3): 173-178, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29771687
4.
Corrigendum: Relacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, Open-Label Phase 2 Study.
Front Endocrinol (Lausanne)
; 13: 899616, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35574017
5.
Relacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, Open-Label Phase 2 Study.
Front Endocrinol (Lausanne)
; 12: 662865, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34335465
6.
The Alzheimer's Prevention Initiative Composite Cognitive Test: a practical measure for tracking cognitive decline in preclinical Alzheimer's disease.
Alzheimers Res Ther
; 12(1): 66, 2020 05 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-32460855
Resultados
1 -
6
de 6
1
Próxima >
>>